$HALO Company News S&P 500 violates major supp
Post# of 89355
Posted On: 01/10/2015 12:18:05 PM
$HALO Company News
S&P 500 violates major support 11:20 a.m. Jan. 7, 2015 - Michael Ashbaugh
Fossil Group swings higher on earnings beat, license renewal 6:30 a.m. Nov. 12, 2014 - Wallace Witkowski
Amazon gains on June event; PVH sinks on results 2:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 8:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 7:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 3:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 5:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 8:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 7:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 11:40 a.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 5:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 1:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 5:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 3:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
'Mad Money' Lightning Round: Be Careful Investing in Google 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:19 p.m. Jan. 9, 2015 - TheStreet.com
Today's Perilous Reversal Stock: Halozyme Therapeutics (HALO) 9:49 a.m. Jan. 9, 2015 - TheStreet.com
Halozyme up on upgrade 12:14 p.m. Jan. 8, 2015 - Seeking Alpha
Barbarian At The Gate: Halozyme Therapeutics (HALO) 9:58 a.m. Jan. 8, 2015 - TheStreet.com
Benzinga's Volume Movers 9:33 a.m. Jan. 8, 2015 - benzinga.com
UPDATE: MLV & Co Raises PT On Halozyme Therapeutics On Promising Start To 2015 8:36 a.m. Jan. 8, 2015 - benzinga.com
Hottest Healthcare Stocks Now – NBIX IPXL HALO VRX 5:45 a.m. Jan. 8, 2015 - InvestorPlace.com
Halozyme Closes In On A Breakout: A Technical Analysis 1:31 p.m. Jan. 7, 2015 - benzinga.com
Hottest Healthcare Stocks Now – HALO NBIX AMAG ENDP 5:45 a.m. Jan. 7, 2015 - InvestorPlace.com
What Investors Are Looking for After Seeing Unusual Options Activity In Halozyme 11:15 a.m. Jan. 6, 2015 - benzinga.com
First Week Of February 2015 Options Trading For Halozyme Therapeutics 10:59 a.m. Dec. 30, 2014 - TheStreet.com
13 Analyst Stocks at $10 and Under With Huge Implied Upside 8:41 a.m. Dec. 27, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – INCY ALXN HALO VRTX 12:45 p.m. Dec. 26, 2014 - InvestorPlace.com
Top Analyst Upgrades and Downgrades: Monsanto, Virgin America and More 8:27 a.m. Dec. 24, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – ACHN BLUE ISIS HALO 7:00 a.m. Dec. 24, 2014 - InvestorPlace.com
MLV & Co Initiates Halozyme Therapeutics With Buy 6:11 a.m. Dec. 24, 2014 - benzinga.com
Halozyme's PEGPH20 tagged an Orphan Drug in Europe 10:31 a.m. Dec. 19, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – PBYI HALO ISIS PRGO 6:30 a.m. Dec. 19, 2014 - InvestorPlace.com
Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog 6:48 p.m. Dec. 18, 2014 - Zacks.com
Critical Alerts For Kinder Morgan, Halozyme Therapeutics, MannKind, BP and Union Pacific Released By InvestorsObserver 9:31 a.m. Jan. 8, 2015 - PR Newswire - PRF
Rallying on Street: Special Research on Dick's Sporting, Monsanto, Halozyme, Janus Capital and Sony 7:30 a.m. Jan. 8, 2015 - PR Newswire - PRF
Halozyme Therapeutics To Present At The 33rd Annual J.P. Morgan Healthcare Conference 4:30 p.m. Jan. 6, 2015 - PR Newswire - PRF
Halozyme Therapeutics Appoints Athena Countouriotis, M.D. as Chief Medical Officer 8:30 a.m. Jan. 5, 2015 - PR Newswire - PRF
Halozyme Therapeutics To Host Analyst And Investor Meeting 9:00 a.m. Dec. 30, 2014 - PR Newswire - PRF
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325414 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Halozyme Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer 8:30 a.m. Dec. 19, 2014 - PR Newswire - PRF
Deal Street: Analyst Coverage on Visteon, Halozyme, Coca-Cola, Groupon and Barrick Gold 9:30 a.m. Dec. 18, 2014 - PR Newswire - PRF
Halozyme Therapeutics Enters A Global Collaboration With Janssen To Develop And Commercialize Subcutaneous Products Using ENHANZE™ Technology 9:00 a.m. Dec. 17, 2014 - PR Newswire - PRF
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio 8:50 a.m. Dec. 12, 2014 - PR Newswire - PRF
Halozyme Announces Presentations Of Preclinical Data At The San Antonio Breast Cancer Symposium Annual Meeting 8:00 a.m. Dec. 12, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The 25th Annual Oppenheimer Healthcare Conference 4:15 p.m. Dec. 3, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 4:15 p.m. Nov. 25, 2014 - PR Newswire - PRF
Halozyme Reports Third Quarter 2014 Financial Results 4:05 p.m. Nov. 10, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference 4:15 p.m. Nov. 5, 2014 - PR Newswire - PRF
Halozyme to Host Third Quarter 2014 Financial Results Conference Call 4:15 p.m. Nov. 3, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 7:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant 7:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Halozyme Announces Podium Presentation On PEGPH20 At The New York Academy Of Sciences 8:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
S&P 500 violates major support 11:20 a.m. Jan. 7, 2015 - Michael Ashbaugh
Fossil Group swings higher on earnings beat, license renewal 6:30 a.m. Nov. 12, 2014 - Wallace Witkowski
Amazon gains on June event; PVH sinks on results 2:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 8:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 7:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 3:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 5:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 8:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 7:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 11:40 a.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 5:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 1:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 5:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 3:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
'Mad Money' Lightning Round: Be Careful Investing in Google 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:19 p.m. Jan. 9, 2015 - TheStreet.com
Today's Perilous Reversal Stock: Halozyme Therapeutics (HALO) 9:49 a.m. Jan. 9, 2015 - TheStreet.com
Halozyme up on upgrade 12:14 p.m. Jan. 8, 2015 - Seeking Alpha
Barbarian At The Gate: Halozyme Therapeutics (HALO) 9:58 a.m. Jan. 8, 2015 - TheStreet.com
Benzinga's Volume Movers 9:33 a.m. Jan. 8, 2015 - benzinga.com
UPDATE: MLV & Co Raises PT On Halozyme Therapeutics On Promising Start To 2015 8:36 a.m. Jan. 8, 2015 - benzinga.com
Hottest Healthcare Stocks Now – NBIX IPXL HALO VRX 5:45 a.m. Jan. 8, 2015 - InvestorPlace.com
Halozyme Closes In On A Breakout: A Technical Analysis 1:31 p.m. Jan. 7, 2015 - benzinga.com
Hottest Healthcare Stocks Now – HALO NBIX AMAG ENDP 5:45 a.m. Jan. 7, 2015 - InvestorPlace.com
What Investors Are Looking for After Seeing Unusual Options Activity In Halozyme 11:15 a.m. Jan. 6, 2015 - benzinga.com
First Week Of February 2015 Options Trading For Halozyme Therapeutics 10:59 a.m. Dec. 30, 2014 - TheStreet.com
13 Analyst Stocks at $10 and Under With Huge Implied Upside 8:41 a.m. Dec. 27, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – INCY ALXN HALO VRTX 12:45 p.m. Dec. 26, 2014 - InvestorPlace.com
Top Analyst Upgrades and Downgrades: Monsanto, Virgin America and More 8:27 a.m. Dec. 24, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – ACHN BLUE ISIS HALO 7:00 a.m. Dec. 24, 2014 - InvestorPlace.com
MLV & Co Initiates Halozyme Therapeutics With Buy 6:11 a.m. Dec. 24, 2014 - benzinga.com
Halozyme's PEGPH20 tagged an Orphan Drug in Europe 10:31 a.m. Dec. 19, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – PBYI HALO ISIS PRGO 6:30 a.m. Dec. 19, 2014 - InvestorPlace.com
Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog 6:48 p.m. Dec. 18, 2014 - Zacks.com
Critical Alerts For Kinder Morgan, Halozyme Therapeutics, MannKind, BP and Union Pacific Released By InvestorsObserver 9:31 a.m. Jan. 8, 2015 - PR Newswire - PRF
Rallying on Street: Special Research on Dick's Sporting, Monsanto, Halozyme, Janus Capital and Sony 7:30 a.m. Jan. 8, 2015 - PR Newswire - PRF
Halozyme Therapeutics To Present At The 33rd Annual J.P. Morgan Healthcare Conference 4:30 p.m. Jan. 6, 2015 - PR Newswire - PRF
Halozyme Therapeutics Appoints Athena Countouriotis, M.D. as Chief Medical Officer 8:30 a.m. Jan. 5, 2015 - PR Newswire - PRF
Halozyme Therapeutics To Host Analyst And Investor Meeting 9:00 a.m. Dec. 30, 2014 - PR Newswire - PRF
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325414 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Halozyme Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer 8:30 a.m. Dec. 19, 2014 - PR Newswire - PRF
Deal Street: Analyst Coverage on Visteon, Halozyme, Coca-Cola, Groupon and Barrick Gold 9:30 a.m. Dec. 18, 2014 - PR Newswire - PRF
Halozyme Therapeutics Enters A Global Collaboration With Janssen To Develop And Commercialize Subcutaneous Products Using ENHANZE™ Technology 9:00 a.m. Dec. 17, 2014 - PR Newswire - PRF
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio 8:50 a.m. Dec. 12, 2014 - PR Newswire - PRF
Halozyme Announces Presentations Of Preclinical Data At The San Antonio Breast Cancer Symposium Annual Meeting 8:00 a.m. Dec. 12, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The 25th Annual Oppenheimer Healthcare Conference 4:15 p.m. Dec. 3, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 4:15 p.m. Nov. 25, 2014 - PR Newswire - PRF
Halozyme Reports Third Quarter 2014 Financial Results 4:05 p.m. Nov. 10, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference 4:15 p.m. Nov. 5, 2014 - PR Newswire - PRF
Halozyme to Host Third Quarter 2014 Financial Results Conference Call 4:15 p.m. Nov. 3, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 7:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant 7:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Halozyme Announces Podium Presentation On PEGPH20 At The New York Academy Of Sciences 8:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
(0)
(0)